ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 82 filers reported holding ARBUTUS BIOPHARMA CORP in Q4 2020. The put-call ratio across all filers is 1.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,000 | +972.7% | 116,174 | +1089.7% | 0.00% | – |
| Q2 2023 | $22,000 | -92.1% | 9,765 | -89.4% | 0.00% | – |
| Q1 2023 | $277,000 | +27.1% | 91,779 | -2.2% | 0.00% | – |
| Q4 2022 | $218,000 | +23.2% | 93,843 | +1.4% | 0.00% | – |
| Q3 2022 | $177,000 | -47.0% | 92,541 | -24.7% | 0.00% | – |
| Q2 2022 | $334,000 | -13.9% | 122,967 | -5.5% | 0.00% | – |
| Q1 2022 | $388,000 | -32.6% | 130,175 | -12.1% | 0.00% | – |
| Q4 2021 | $576,000 | -7.1% | 148,090 | +2.5% | 0.00% | – |
| Q3 2021 | $620,000 | +246.4% | 144,437 | +145.2% | 0.00% | – |
| Q2 2021 | $179,000 | +8850.0% | 58,895 | +10089.4% | 0.00% | – |
| Q1 2021 | $2,000 | -96.4% | 578 | -96.2% | 0.00% | – |
| Q4 2020 | $55,000 | +27.9% | 15,376 | +10.8% | 0.00% | – |
| Q3 2020 | $43,000 | +186.7% | 13,879 | +67.8% | 0.00% | – |
| Q2 2020 | $15,000 | +400.0% | 8,269 | +242.7% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 2,413 | +88.1% | 0.00% | – |
| Q4 2019 | $3,000 | -72.7% | 1,283 | -82.3% | 0.00% | – |
| Q3 2019 | $11,000 | -21.4% | 7,252 | +9.7% | 0.00% | – |
| Q2 2019 | $14,000 | -39.1% | 6,610 | +0.6% | 0.00% | – |
| Q1 2019 | $23,000 | -11.5% | 6,571 | -3.0% | 0.00% | – |
| Q4 2018 | $26,000 | -75.0% | 6,773 | -38.7% | 0.00% | – |
| Q3 2018 | $104,000 | +73.3% | 11,056 | +37.0% | 0.00% | – |
| Q2 2018 | $60,000 | -20.0% | 8,073 | -46.2% | 0.00% | – |
| Q1 2018 | $75,000 | +36.4% | 14,999 | +37.7% | 0.00% | – |
| Q4 2017 | $55,000 | -14.1% | 10,895 | +5.2% | 0.00% | – |
| Q3 2017 | $64,000 | +28.0% | 10,355 | -25.3% | 0.00% | – |
| Q2 2017 | $50,000 | +8.7% | 13,855 | -0.9% | 0.00% | – |
| Q1 2017 | $46,000 | -11.5% | 13,980 | -34.1% | 0.00% | – |
| Q4 2016 | $52,000 | +15.6% | 21,230 | +63.9% | 0.00% | – |
| Q3 2016 | $45,000 | -2.2% | 12,950 | -1.8% | 0.00% | – |
| Q2 2016 | $46,000 | -17.9% | 13,190 | -2.9% | 0.00% | – |
| Q1 2016 | $56,000 | -17.6% | 13,590 | -12.0% | 0.00% | – |
| Q4 2015 | $68,000 | -84.1% | 15,450 | -78.0% | 0.00% | – |
| Q3 2015 | $428,000 | – | 70,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |